Ion charge density governs selectivity in the formation of metal-Xylenol Orange (M-XO) complexes

被引:23
作者
Belleza, Oliver John V. [1 ]
Villaraza, Aaron Joseph L. [1 ]
机构
[1] Univ Philippines Diliman, Coll Sci, Inst Chem, Quezon City 1101, Metro Manila, Philippines
关键词
Xylenol Orange; Metal ions; Ion charge density; MRI contrast agents; NEPHROGENIC SYSTEMIC FIBROSIS; CONTRAST AGENTS;
D O I
10.1016/j.inoche.2014.07.024
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Clinically-approved Magnetic Resonance Imaging (MRI) contrast agents (CAs) are Gd-based small-molecule chelates which possess high thermodynamic stability and kinetic inertness in vivo. Free Gd3+ ion in plasma is toxic and has been implicated in Nephrogenic Systemic Fibrosis (NSF) in renally-compromised patients. Any preparation of Gd-based MRI CAs must therefore be carefully examined for the presence of free Gd3+ ion. A simple assay involves the use of Xylenol Orange (XO) as a colorimetric indicator under slightly acidic (pH = 5.8) buffered conditions. However, the structure of XO suggests that other ions possessing similar ionic size and/or coordination number could form complexes with XO as well. In this study, we investigated the complexation of XO with other metal ions, namely, Ca2+, Mn2+, Zn2+ and Tb3+, by UV-Vis absorption spectroscopy and compared these results with those of Gd-XO solutions. Ligand-to-metal ratios were determined using Job plots, and the relative stabilities of the complexes were investigated by competition with EDTA. In summary, XO can be used to detect Gd3+, Tb3+ and Zn2+ at the same concentration (<1 mu M) range, but not Mn2+ and Ca2+ which form M-XO only at higher concentrations. This discrepancy was rationalized by differences in ion charge density. Hence, XO can be used to discriminate between, for example, Gd3+ and Ca2+, but not between Gd3+, Tb3+ or Zn2+. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 19 条
[1]   How to determine free Gd and free ligand in solution of Gd chelates. A technical note [J].
Barge, Alessandro ;
Cravotto, Giancarlo ;
Gianolio, Eliana ;
Fedeli, Franco .
CONTRAST MEDIA & MOLECULAR IMAGING, 2006, 1 (05) :184-188
[2]   MR contrast agents, the old and the new [J].
Bellin, Marie-France .
EUROPEAN JOURNAL OF RADIOLOGY, 2006, 60 (03) :314-323
[3]   Use of xylenol orange and cetylpyridinium chloride in rapid spectrophotometric determination of zinc in pharmaceutical products [J].
Benamor, M ;
Belhamel, K ;
Draa, MT .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 23 (06) :1033-1038
[4]   Gadodiamide-associated nephrogenic systemic fibrosis: Why radiologists should be concerned [J].
Broome, Dale R. ;
Girguis, Mark S. ;
Baron, Pedro W. ;
Cottrell, Alfred C. ;
Kjellin, Ingrid ;
Kirk, Gerald A. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (02) :586-592
[5]   Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications [J].
Caravan, P ;
Ellison, JJ ;
McMurry, TJ ;
Lauffer, RB .
CHEMICAL REVIEWS, 1999, 99 (09) :2293-2352
[6]  
Cheng K., 1959, Talanta, V3, P147, DOI [10.1016/0039-9140(59)80193-4, DOI 10.1016/0039-9140(59)80193-4]
[7]   Determination of iron in solutions with the ferric-xylenol orange complex [J].
Gay, C ;
Collins, J ;
Gebicki, JM .
ANALYTICAL BIOCHEMISTRY, 1999, 273 (02) :143-148
[8]   Lanthanide Probes for Bioresponsive Imaging [J].
Heffern, Marie C. ;
Matosziuk, Lauren M. ;
Meade, Thomas J. .
CHEMICAL REVIEWS, 2014, 114 (08) :4496-4539
[9]   A practical guide for the determination of binding constants [J].
Hirose, K .
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2001, 39 (3-4) :193-209
[10]   Formation and Extraction of Niobium(V) Complex with Xylenol Orange in the Presence of a 4-Pyridone Derivative [J].
Ivsic, A. Gojmerac ;
Galic, N. ;
Tomisic, V. .
JOURNAL OF SOLUTION CHEMISTRY, 2009, 38 (02) :149-158